Two ASX 300 shares that have earned a positive rating from Bell Potter after earnings results are Imdex Ltd (ASX: IMD) and McMillan Shakespeare Ltd (ASX: MMS).
Both companies released H1 FY26 results yesterday which led to buy recommendations from the broker.
Here is what both ASX 300 companies reported.
Imdex Ltd (ASX: IMD)
Imdex is an Australian mining equipment and technology company operating globally.
Its share price has been on a steady increase over the last 12 months, rising 30.7% in that span.
This continued yesterday as its share price rose 2.5% on the back of its 1H FY26 Results.
For the half year ending 31 December 2025 this ASX 300 company reported:
- Revenue of $247 million, up 16% on prior corresponding period (pcp)
- EBITDA normalised $78 million, up 22% on pcp.
- Interim dividend of 1.7 cps.Â
Speaking on the results, Managing Director and Chief Executive Officer, Paul House, said:
I am delighted with the record 1H26 result, two things stand out to me. The first being our commitment to invest continually through the exploration cycle that continues to build on a portfolio of leading technology. The second being our unrivalled global network and team of IMDEX personnel around the world working relentlessly to deliver value for our customers. This combination has enabled IMDEX to once again outperform the market.
McMillan Shakespeare Ltd (ASX: MMS)
It was a different reaction from the market after this ASX 300 company released half-year results yesterday.
It’s share price fell more than 5% as investors were seemingly discouraged by the results.
This ASX 300 company specialises in employee benefits.
Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.
For the six months ending 31st December 2025, it reported:
- Statutory net profit after tax (NPAT) up 9.7% to $49.6 million
- Underlying net profit after tax and amortisation (UNPATA) up 1.4% to $50.3 million
- Group revenue up 11.2% to $297.4 million
- Half-year fully-franked dividend of 62 cents
Bell Potter upgrades both ASX 300 companies
Bell Potter previously had a hold recommendation on both stocks, but has now upgraded both to a buy.
Responding to the results from Imdex, Bell Potter said it was highly encouraged by the CY26 global gold and copper Major and Intermediate budgets announced to date, implying a significant uplift in exploration spend compared with CY25.
Together, with greater Junior exploration activity, as a record wave of recently raised equity is deployed, we believe IMD will see robust demand growth for its products and services and operating leverage.
The broker has upgraded its share price target to $4.60 (previously $3.60).
From yesterday’s closing price of $4.00, this indicates an upside of 15%.
Meanwhile, for McMillan Shakespeare shares, the broker was optimistic about future growth thanks to the company’s disciplined cost control.
We view the result as being classified by disciplined cost control. MMS could see as much as +8% benefit at EBITDA line from non-recurring costs and productivity alone. We upgrade to Buy on the depressed multiple and upgrade our EPS +2%/+0%/+0%.
The broker has an updated price target of $18.50 (previously $19.70).
From yesterday’s closing price, this indicates an upside of approximately 11.4%.
The post Bell Potter just upgraded these ASX 300 shares to a buy after earnings results appeared first on The Motley Fool Australia.
Should you invest $1,000 in Imdex Limited right now?
Before you buy Imdex Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Imdex Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended McMillan Shakespeare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.